References
- Abraham G. E., Maroulis G., Marshall J. R. Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Oct, 1974, Obstet Gyn-ecol 44. No. 4
- Andersson D. C. Sex hormone binding globulin. Clin Endocrinol 1974; 3: 69
- Brenner P. F., Jr., Mishell R. D. Menopause. Reproductive Endocrinology, Infertility and Contraception, D. R. Mishell, Jr., V. Davajan. F. A. Davis Co., Philadelphia 1979; 161
- Damber J.-E., Jansson P. O. The effects of LH, adrenaline and noradrenaline on testicular blood flow and plasma testosterone concentrations in anaesthetized rats. Acta Endocrinol (Copenh) 1978; 88: 390
- El Makhzangy M. N., Wynn V., Lawrence D. M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39
- Hagstad A., Samsioe G. Lipid metabolic effects induced by two estradiol/norgestrel combinations in women around forty. Acta Obstet Gynecol Scand Suppl 1982; 106: 57
- Harris G., Naftolin F. The hypothalamus and control of ovulation. Br Med Bull 1970; 26: 3
- Helgason S., Damber J.-E., Damber M.-G., von Schoultz B., Selstam G., Södergård R. A comparative longitudinal study on sex hormone binding glo-bulin capacity during estrogen replacement therapy. Acta Obstet Gynecol Scand 1982; 61: 97
- Larsson B., Hamberger L., Rybo G. Influence of copper intrauterine contraceptive devices (Cu-7-IUD) on the menstrual blood-loss. Acta Obstet Gynecol Scand 1975; 54: 315
- Metcalf M. G. Incidence of ovulatory cycles in women approaching the menopause. J Biosoc Sci 1979; 11: 39
- Ottosson U.-B., Damber J.-E., Damber M.-G., Selstam G., Solheim F., Stigbrand T., Södergård R., von Schoultz B. Effects on sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinylestradiol and nor-ethisterone. Maturitas 1981; 3: 295
- Richardson G. B. Ovarian Physiology. J & A Churchill Ltd., London 1967; 122
- Rodkey F. L. Direct spectrophotometric determination of albumin in human serum. Clin Chim Acta 1965; 11: 478
- Royal College of General Practitioners. Further analysis of mortality in oral contraceptive users. Lancet 1981; i: 541
- Samsioe G., Skryten A., Silfverstolpe G. Oral contraception with a non-alkylated estrogen component. Effects on lipid metabolism. Gynecol Obstet Invest 1983; 15: 275
- Schneider W. H. F., Spona J. Experimental and clinical data on Cyclabil. Acta Obstet Gynecol Scand, Suppl 1977; 65: 39
- Shanbag V. P., Södergård R., Carstensen H., Albertsson P.-A. A new method for the determination of the binding capacity of testosterone-estradiol. binding globulin in human plasma. J Steroid Biochem 1973; 4: 537
- Sharman A. The Ovary, H. Suckerman, New York 1962; vol. 1: 645
- Silfverstolpe G., Gustafson A., Samsioe G., Svan-Borg A. Lipid metabolic studies in oophorectomized women. Effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol Obstet Invest 1980; 11: 161
- Stumpf P. G., Nakamura R. M., Mishell D. R., Jr. Changes in physiologically free circulation estradiol and testosterone during exposure to levonorgestrel. J Clin Endocrinol Metab 1981; 52: 138
- Victor A., Weiner E., Johansson E. D. B. Sex hormone binding globulin: The carrier protein for d-nor-gestrel. J Clin Endocrinol Metab 1976; 43: 244
- Victor A., Johansson E. O. B. Effects of rf-nor-gestrel induced decreases in sex hormone binding globulin capacity in the d-norgestrel levels in plasma. Contraception 1977; 16: 115